EP Patent
EP3501584B1 — Compliance monitoring module for a breath-actuated inhaler
Assigned to Norton Waterford Ltd · Expires 2020-09-30 · 6y expired
What this patent protects
Patent listed against Cutivate.
Drugs covered by this patent
- Cutivate (FLUTICASONE PROPIONATE) · Teva Pharm
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.